WP
TEVA icon

WealthShield Partners’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

WealthShield Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,830
Closed -$477K – 587
2026
Q1 		$477K Sell
15,830
-166
-1% -$5.34K 0.05% 246
2025
Q4 		$499K Hold
15,996
– – 0.06% 243
2025
Q3 		$323K Hold
15,996
– – 0.04% 276
2025
Q2 		$268K Buy
15,996
+996
+7% +$16.1K 0.03% 290
2025
Q1 		$231K Hold
15,000
– – 0.03% 295
2024
Q4 		$331K Hold
15,000
– – 0.05% 238
2024
Q3 		$270K Hold
15,000
– – 0.04% 256
2024
Q2 		$244K Buy
+15,000
New +$231K 0.04% 256
2022
Q2 		– Sell
-17,996
Closed -$169K – 332
2022
Q1 		$169K Buy
+17,996
New +$150K 0.03% 321

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

WealthShield Partners's TEVA Position: Q2 2026 in Review

WealthShield Partners sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026, closing a stake of 15,830 shares — an estimated $477K sold.

WealthShield Partners first reported a position in TEVA in Q1 2022 and held it in 9 quarters. The position peaked at $499K in Q4 2025. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • WealthShield Partners reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2026 after selling out during the quarter.
  • WealthShield Partners sold 15,830 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $477K.
  • WealthShield Partners first reported a position in Teva Pharmaceutical Industries Limited in Q1 2022 and held it in 9 quarters.
  • WealthShield Partners's Teva Pharmaceutical Industries Limited position peaked at $499K in Q4 2025.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on WealthShield Partners's 13F filing for Q2 2026, filed 12 Aug 2026.